Melanotan 1 is a synthetic peptide analog of α-MSH (alpha-melanocyte stimulating hormone). It works by activating melanocortin-1 receptors (MC1R) to stimulate melanin production, offering natural skin pigmentation and photoprotection.
It has been approved for the treatment of erythropoietic protoporphyria (EPP)—a rare disorder causing extreme sensitivity to sunlight. Melanotan 1 helps increase tolerance to UV light, reduce phototoxic reactions, and enhance skin defense against UV-induced damage.
Selective MC1R agonist
Increases eumelanin production
Provides natural sun protection
Supports DNA repair and anti-inflammatory response
Potential for vitiligo, skin cancer prevention, and cosmetic pigmentation
Explored in anti-aging and dermatological therapies
High purity ≥99%
Solid-phase peptide synthesis (SPPS)
GMP-like manufacturing standards
Scalable supply: R&D to commercial levels